Stockholm captain raises EUR 1.39 million to market his new blood sample kit

Cupertino, March 11, 2020

The Swedish startup, Capitainer, announced today that it has closed a EUR 1.39 million share to market its new dried blood sampling solution, Capitainer qDBS. The new disposable kit can be used at home by professionals who do not have healthcare and eliminates the risk of human error. US-based Nordic Consumer Health and Wolf Family Trust led the round, which was joined by a consortium of Nordic angel investors and Capitainer management.

Capitainer, founded in 2013, has developed an easy-to-use solution for home blood sampling, which will be revolutionary for patients in need of ongoing monitoring, as well as saving travel and healthcare resources. The new single-use sampling chip can measure and store an exact volume of blood that allows quantitative measurement, which has not been possible so far. Patients can themselves conveniently drop off samples and mail them to a lab for analysis, without the need for refrigeration or specialized packaging.

The potential impact of this new kit could be huge, as more than one million samples of therapeutic drug monitoring are taken each year in Sweden alone. In addition to providing cost savings, the kit will also improve medical efficiency and patient experience and reduce the environmental impact.

Mats Bergryd, CEO of Nordic Consumer Health, said: "Currently, the size of the dry blood collection market is expected to reach $ 337.3 million by 2026, growing at a CAGR of 3.5%. However, with our next-generation device, Capitainer qDBS, with quantitative and easy-to-use sampling, not only will we expand the existing market, but we will also be able to enter the home-based clinical sampling market, which we believe is a $ 1 billion market. We aim to make Capitainer products the new gold standard for blood sampling at home. As a founding investor, we are pleased to lead this round and look forward to a successful marketing. ”

Bob Wolf, founder and president of specialty Diagnostix, said: "From wellness screening to serologic diagnosis of infectious and autoimmune diseases, the potential for Capitainer qDBS to further increase its already positive impact on health benefits and outcomes is enormous and we are excited to invest in this round."

EUStartups Summit banner

Best selling & Top trending HomeKit product in our shop at this moment

HomeKit.Blog is in no way affiliated with or endorsed by Apple Inc. or Apple related subsidiaries.

All images, videos and logos are the copyright of the respective rights holders, and this website does not claim ownership or copyright of the aforementioned.

All information about products mentioned on this site has been collected in good faith. However, the information relating to them, may not be 100% accurate, as we only rely on the information we are able to gather from the companies themselves or the resellers who stock these products, and therefore cannot be held responsible for any inaccuracies arising from the aforementioned sources, or any subsequent changes that are made that we have not been made aware of.

HomeKit.Blog Is A Participant In The Amazon Services LLC Associates Program, An Affiliate Advertising Program Designed To Provide A Means For Sites To Earn Advertising Fees By Advertising And Linking To Amazon Store (Amazon.com, Or Endless.com, MYHABIT.com, SmallParts.com, Or AmazonWireless.com).

The opinions expressed on this website by our contributors do not necessarily represent the views of the website owners. 

Copyright © 2022 HomeKit Blog
. All rights reserved
United States